Suppr超能文献

肝脏再次移植:单中心经验

Liver retransplantation: a single-centre experience.

作者信息

Ma Yi, Wang Guo-dong, He Xiao-shun, Li Jun-liang

机构信息

Organ Transplantation Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.

出版信息

Chin Med J (Engl). 2008 Oct 20;121(20):1987-91.

Abstract

BACKGROUND

The curative effect of liver transplantation for patients with end-stage liver disease was encouraging in recent years and the 5-year patient survival rate can reach up to 70%. However, some patients might lose grafts due to a variety of reasons, including bile duct complications, vascular complications, primary non-function, graft rejection and disease recurrence etc. Liver retransplantation (re-LT) was the only available means for those patients whose initial grafts had failed, but the inferior outcomes of re-LT compared to primary liver transplantation (PLT) continue to be a major concern. This study aimed to analyze the indications for re-LT, optimal timing of re-LT, and strategies to improve the survival rate after re-LT.

METHODS

From January 2001 to December 2006, we performed 738 liver transplants and 39 re-LT (5.3%) at our center. A retrospective analysis was performed to identify factors (indication for re-LT, preoperative score of model for end-stage liver disease (MELD), interval to re-LT from primary liver transplantation, methods of vascular and biliary reconstruction and common causes of death) associated with survival.

RESULTS

Mean follow-up period was 1.8 years (1 to 5 years). Patients with MELD score less than 20 were better than those whose MELD score was > 20 and MELD score > 30 (1-year survival, 80.0% versus 50.0% and 3/5). The perioperative survival rate of patients who received re-LT at an interval of more than 30 days and less than 8 days after the initial transplantation was higher than those who received retransplantation between 8 to 30 days following the first operation (88.5% and 74.3% versus 50.0%). The main causes of death were infection (60.0%), multiple organ failure (20.0%), vascular complications (10.0%) and biliary fistula (10.0%) in perioperative period. The overall patient survival rate of 1-month, 6-month and 1-year was 80.0%, 76.7% and 66.7%, respectively.

CONCLUSIONS

Our study suggested the favorable results after re-LT. The analysis also showed optimal timing of operation, refined surgical techniques, individualized immunosuppressive regimen and effective prophylaxis and treatment of perioperative infection play an important role in achieving a higher survival after re-LT.

摘要

背景

近年来,肝移植治疗终末期肝病患者的疗效令人鼓舞,患者5年生存率可达70%。然而,部分患者可能因各种原因失去移植物,包括胆管并发症、血管并发症、原发性无功能、移植物排斥反应及疾病复发等。肝再次移植(re-LT)是初始移植物功能丧失患者的唯一可用治疗手段,但与初次肝移植(PLT)相比,re-LT效果较差仍是主要问题。本研究旨在分析re-LT的适应证、最佳时机及提高re-LT后生存率的策略。

方法

2001年1月至2006年12月,我们中心共进行了738例肝移植手术,其中39例为re-LT(占5.3%)。进行回顾性分析,以确定与生存相关的因素(re-LT适应证、终末期肝病模型(MELD)术前评分、初次肝移植至re-LT的间隔时间、血管和胆管重建方法及常见死亡原因)。

结果

平均随访时间为1.8年(1至5年)。MELD评分小于20的患者比MELD评分>20及MELD评分>30的患者预后好(1年生存率分别为80.0%、50.0%和3/5)。初次移植后间隔超过30天且少于8天接受re-LT的患者围手术期生存率高于初次手术后8至30天接受再次移植的患者(分别为88.5%、74.3%和50.0%)。围手术期死亡的主要原因是感染(60.0%)、多器官功能衰竭(20.0%)、血管并发症(10.0%)和胆瘘(10.0%)。患者1个月、6个月和1年的总体生存率分别为80.0%、76.7%和66.7%。

结论

我们的研究表明re-LT后效果良好。分析还显示,最佳手术时机、精细的手术技术、个体化免疫抑制方案以及围手术期感染的有效预防和治疗对提高re-LT后的生存率起着重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验